✦ LIBER ✦

409 The novel, investigational Nedd8-activating enzyme inhibitor MLN4924 in patients with metastatic melanoma: a phase 1 study

✍ Scribed by O. Hamid; B.J. Dezube; M.D. Pickard; M.A. Shultz; S. Bhatia

Book ID: 119603092
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)72116-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of the potent PARP inhi

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

✍ Ruth Plummer, Paul Lorigan, Neil Steven, Lucy Scott… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 286 KB

A phase 2 study of the insulin-like grow

A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors

✍ Diane L. Reidy-Lagunes; Efsevia Vakiani; Michal F. Segal; Ellen M. Hollywood; La 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

651 POSTER A Phase 1 dose escalation stu

651 POSTER A Phase 1 dose escalation study of ARQ 197, a selective inhibitor of the c-Met receptor in patients with metastatic solid tumors

✍ L. Rosen; A. Garcia; M. Mulay; C. Cunningham; J. Nemunaitis; N. Senzer; C. Li; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Phase 1 clinical trial of the novel prot

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

✍ Michael Millward, Timothy Price, Amanda Townsend, Christopher Sweeney, Andrew Sp 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 688 KB

A Phase 1 Dose Escalation Study of the S

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies

✍ O'Connor, O. A.; Stewart, A. K.; Vallone, M.; Molineaux, C. J.; Kunkel, L. A.; G 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 377 KB

A phase 2 study of oral MKC-1, an inhibi

A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer

✍ Jason E. Faris, Jamie Arnott, Hui Zheng, David P. Ryan, Thomas A. Abrams, Lawren 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 169 KB